一个严重的急性呼吸道冠状病毒2 (SARS-CoV-2) 医院集群与设施间传播:经验教训
Aurora E Pop-Vicas1, Laura Anderson2, Gabrielle Hatas2
1Division of Infectious Disease, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Infection control and hospital epidemiology
|January 4, 2024
概括
在SARS-CoV-2三角洲激增期间,严格的感染控制措施成功结束了高风险医疗机构的COVID-19疫情. 这些干预措施防止了进一步的医院传播,保护了脆弱的患者和工作人员.
科学领域:
- 传染性疾病 传染性疾病
- 流行病学 流行病学
- 医疗保健管理的管理
背景情况:
- 尽管有感染控制指南,2019年新型冠状病毒病 (COVID-19) 爆发仍在持续.
- 这项研究详细介绍了一种复杂的严重急性呼吸道冠状病毒2 (SARS-CoV-2) 集群,在SARS-CoV-2三角洲变种大流行期间跨设施传播.
研究的目的:
- 描述一个涉及学术医疗中心血液瘤病房和急性康复医院的SARS-CoV-2集群.
- 评估实施的感染控制干预措施在停止医院传播方面的有效性.
主要方法:
- 对COVID-19病例进行了接触追踪,以在14天内确定医疗保健暴露.
- 在患者和医疗保健工作者 (HCW) 中进行了无症状运输的自由测试.
- 利用SARS-CoV-2分离体的全基因组测序来识别传播集群.
主要成果:
- 在免疫抑制病房发生了一组19例病例 (4名患者,15名HCW) 与遗传相关的SARS-CoV-2分离物发生; 4名患者中有3人死亡.
- 康复医院报告了20例COVID-19病例,其中5例 (2名患者,3名HCW) 与最初的集群有关.
- 干预措施包括访问者/学习者的限制,入场限制,加强个人防护设备 (PPE) 合规性,频繁的现场测试以及退院/转移前的测试.
结论:
- 严格的感染控制措施在预防高风险医疗机构的医院COVID-19传播在流行病激增期间是有效的.
- 实施的干预措施成功终止了所描述的疫情.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


